The challenging issue of polydrug consumption: new trends of a deep-seated public health threat
Keywords:
Polydrug use, Substance abuse, Screening and detectionReferences
Di Trana A, Carlier J, Berretta P, Zaami S, Ricci G. Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances. Front Psychiatry 2020; 11: 584462.
UNODC. World drug report 2022 Global overview: drug demand drug supply [Internet]. 2022 [cited 2022 Apr 13]. Available from: www.unodc.org/unodc/en/data-and-analysis/wdr2021.html
European Monitoring Centre for Drugs and Drug Addiction (2022), European Drug Report 2022: Trends and Developments, Publications Office of the European Union, Luxembourg. https://www.emcdda.europa.eu/system/files/publications/14644/TDAT22001ENN.pdf
Rock KL, Englund A, Morley S, Rice K, Copeland CS. Can cannabis kill? Characteristics of deaths following cannabis use in England (1998-2020). J Psychopharmacol 2022 Aug 10:2698811221115760.
Zaami S, Busardò FP, Pichini S, Pacifici R, Marinelli E. The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances. Eur Rev Med Pharmacol Sci 2019; 23: 6008-6010.
Mannocchi G, Di Trana A, Tini A, et al. Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases. Anal Bioanal Chem 2020; 412: 5125-5145.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Annagiulia Di Trana
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.